‘Magic mushroom’ treatment for depression edges closer to approval

Psilocybinthe hallucinogen in “magic mushrooms”, may help treat severe depression, according to the largest ever trial of therapeutic emission.

First trial data were published in November 2021, but these results were not peer-reviewed at the time. The new peer-reviewed report, published Wednesday, November 2 in the New England Journal of Medicine (opens in a new tab)comes out as trial organizers prepare to launch an even larger trial, called a Phase 3 trial, which will provide the data needed for Food and Drug Administration (FDA) approval.


Dial 988 or 1-800-273-TALK (8255) to access free assistance from a nationwide network of local crisis centers. You also have the possibility to chat online (opens in a new tab).

Leave a Reply

Your email address will not be published. Required fields are marked *